Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share Price (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,639.00
Bid: 1,638.50
Ask: 1,639.00
Change: -0.50 (-0.03%)
Spread: 0.50 (0.031%)
Open: 1,650.50
High: 1,656.00
Low: 1,637.00
Prev. Close: 1,639.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Gsk Plc Ord 31 1/4p

Glaxosmithkline is listed in the FTSE All-Share, FTSE 350 High Yield, FTSE 350, FTSE 100 indices.

Glaxosmithkline is listed in the Medicine and Biotech sector.

Gsk Plc Ord 31 1/4p is listed on the London Stock Exchange trading with ticker code GSK.L. It has a market capitalisation of £66.97b, with approximately 4.09b shares in issue. Over the last year, Glaxosmithkline share price has been traded in a range of 417.20, hitting a high of 1,719.80, and a low of 1,302.60.

Glaxosmithkline Share Price
Price 1,639.00
Bid 1,638.50
Ask 1,639.00
Change -0.50 (-0.03%)
Volume 1,173,976
Open 1,650.50
High 1,656.00
Low 1,637.00
Prev. Close 1,639.50
Currency GBX
Issue Country GB
Shares in Issue 4.09b
Market Capitalisation £66.97b
Market Size 1,500
52 Week High 1,719.80
52 Week High Date 07-Mar-2024
52 Week Low 1,302.60
52 Week Low Date 11-Jul-2023
# Trades 3,324
Vol. Sold 499,869
Sold Value £8.24m
Vol. Bought 562,875
Bought Value £9.28m
PE Ratio 13.47862
Earnings 121.60
Dividend 55.50
Yield 3.386%
Great for
Spread Betting and CFDs
Capital at risk.
Go to site
Great for
0% commission
Other fees apply.
Capital at risk.
Go to site
Great for
Larger Investment Pots
Capital at risk.
Go to site
Great for
Low Fees
Capital at risk.
Go to site

Recent Share Trades for Glaxosmithkline (GSK)

Date Time Trade Prc Volume Buy/Sell Bid Ask Value  
23-Apr-2414:17:191,639.00321Sell*1,639.001,639.505,261A Automatic Execution
23-Apr-2414:15:461,640.0010Buy*1,639.001,640.00164.00A Automatic Execution
23-Apr-2414:15:441,639.4394900Sell*1,639.001,640.0014.75kO Ordinary
23-Apr-2414:15:371,639.991Buy*1,639.001,640.0016.40O Ordinary
23-Apr-2414:15:361,639.50105Unknown*1,639.001,640.001,721O Ordinary
23-Apr-2414:15:161,639.50246Buy*1,639.001,639.504,033A Automatic Execution
23-Apr-2414:15:161,639.5073Buy*1,639.001,639.501,197A Automatic Execution
23-Apr-2414:15:161,639.50175Buy*1,639.001,639.502,869A Automatic Execution
23-Apr-2414:15:091,639.50473Sell*1,639.501,640.007,755A Automatic Execution
23-Apr-2414:15:091,639.50429Sell*1,639.501,640.007,033A Automatic Execution

Directors Deals for Glaxosmithkline (GSK)

Announced Traded Action Notifier Price Currency Amount Holding
19-Apr-2416-Apr-24Buy DividendsHal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron39.79USD2,906,2133,370,704
19-Apr-2416-Apr-24Buy DividendsEmma Walmsley held the position of CEO at the time of this trade.Emma Walmsley1,611.28GBX1,840,9222,190,842
15-Apr-2412-Apr-24Buy DividendsAnne Beal held the position of Independent Non-Executive Director at the time of this trade.Anne Beal40.96USD93,375
15-Apr-2412-Apr-24Buy DividendsHarry (Hal) C. Dietz held the position of Independent Non-Executive Director at the time of this trade.Harry (Hal) C. Dietz40.96USD93,118
15-Apr-2412-Apr-24Buy DividendsHal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron40.96USD13464,491
Glaxosmithkline

At GSK, we unite science, technology and talent to get ahead of disease together

Glaxosmithkline Home Page

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.